Drug
Simenepag isopropyl clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses simenepag isopropyl is read from its arms, and is right about nine times in ten.
Testing it · 3
- Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 2AllerganNCT01291108Written as AGN-210669
- Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedPhase 1/2AllerganNCT00809848Written as AGN-210669 ophthalmic solution, 0.075%
- Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic SolutionCompletedPhase 2AllerganNCT01001195Written as AGN-210669 ophthalmic solution, 0.1%
Codes
What other systems call simenepag isopropyl · ClinicalTrials.gg INT015626
- UNII (FDA) 8908HU0G4KSIMENEPAG ISOPROPYLConfirmed FDA, Wikidata
- Wikidata Q27269976simenepag isopropylConfirmed FDA, Wikidata
- NCI Thesaurus C152363Simenepag IsopropylOne source FDA
- DrugBank DB12977One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8908HU0G4K | SIMENEPAG ISOPROPYL | Confirmed FDA, Wikidata |
| Wikidata | Q27269976 | simenepag isopropyl | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152363 | Simenepag Isopropyl | One source FDA |
| DrugBank | DB12977 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.